Dr. Pat Soon-Shiong
@DrPatrick
Chairman of Chan Soon-Shiong Family Foundation, Exec Chairman ImmunityBio, Chairman and Chief Executive Officer of Los Angeles Times Media Group (LATMG)
You might like
My meeting with @POTUS and HRH MBS in May 2025 resulted in such amazing results and action! In less than a year we received the world’s first approval for lung cancer for the Bioshield… and now we have established a wholly owned subsidiary in the Kingdom to support physicians
It started with a handshake in Riyadh. May 2025. Two world leaders. One mission: bring immunotherapy to mankind and cure cancer. Less than a year later — EU authorization across 33 countries. The world's first lung cancer approval of the Bioshield in Saudi. Distribution
ImmunityBio is forging new ground in the Middle East with a regional office in Saudi Arabia and a commercial partnership with Biopharma Cigalah. This initiative supports clinicians and health systems throughout the Middle East and North Africa, furthering our mission to extend
So proud of @paugasol elected Chair of the IOC Athletes Commission and IOC Executive Board member today in @milanocortina26. Delightful meeting with President Kirsty Coventry where we discussed shared values of engaging communities with the shared spirit of sports as a
Saudi Arabia is positioning itself to establish the most modernized biotech industry based on AI driven discovery tied to AI driven robotic manufacturing system tied to outcomes for healthspan based on immunotherapy and cell therapy biological systems..immunotherapy 2.0 and
Saudi Arabia’s Vision 2030 establishes the Kingdom as a next-generation biotech hub, reflecting a modern, forward-thinking commitment to innovation and full integration as a national priority. youtu.be/l_MRxcDjpGc?si…
youtube.com
YouTube
Saudi Arabia’s Vision 2030 Positions the Kingdom as a Next-Generation...
We have now initiated the process of establishing the WORLD BANK OF NATURAL KILLER CELLS and identified global cancer centers where our robots will be installed. Imagine if this can now be automated so that TRILLIONS OF NK cells can be stored and even engineered as CAR-NK cell
We're advancing global access to ANKTIVA®. A new distribution partnership with Accord Healthcare and the launch of an Irish subsidiary will expand commercialization efforts across ~30 countries, bringing this important therapy closer to eligible patients with BCG-unresponsive
So exciting to see the results of Anktiva in bladder cancer in women who tend to have higher-grade and more advanced tumors, resulting in a higher risk of recurrence and lower survival rates compared to men. Grateful for Deborah allowing us to tell her story of papillary
100 Sales, Medical, and Marketing professionals..News soon on how we are moving rapidly to execute on the delivery of Anktiva on a global basis! Stay tuned.
Moving forward with the greatest speed of bringing NK cell therapy to the Middle East. Met wit Major cancer centers in Riyadh and Abu Dhabi with incredible oncology expertise who are so enthusiastic to combine Anktiva with CAR-NK cell therapy across both liquid and solid tumors.
Great meeting with leadership at UAE - from regulatory agencies to cancer delivery centers of the highest standards at Cleveland Clinic in Abu Dhabi @ClevelandClinic UAE
The beat goes on with global approvals of Anktiva. Europe has had NO previous approvals for BCG unresponsive bladder cancer until now. With the approval of Anktiva plus checkpoint in lung cancer as well by the Saudi FDA, the rest of world is recognizing the need to reverse
The European Commission has granted conditional marketing authorization for ANKTIVA® (nogapendekin alfa inbakicept) in combination with BCG for adults with BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ. This decision broadens availability across 33
Exciting, inspiring and motivating meetings in the Middle East. Visiting several countries and so impressed by the recognition by leadership at the highest levels and their urgent drive to improve the health of their citizens, with the desire to implement the most modernized
National preparedness for the next infectious and Non- infectious pandemic is an issue of national security. A shared vision between our countries.
Preparing for the Next Pandemic as a Matter of National Security: A Global, Shared Vision youtube.com/watch?v=FxC-k-…
youtube.com
YouTube
Preparing for the Next Pandemic as a Matter of National Security: A...
Initiating discussions with Saudi FDA for Anktiva for the treatment of multiple tumor types who have failed standard of care, including checkpoint inhibitors. Excited about the submission of the recombinant BCG to address the shortage issue in Saudi Arabia.
What a productive day. From a scientific clinical and regulatory review with the entire leadership and thought leaders in Saudi to actionable next steps of the USA-Saudi Biotech Alliance. Invited to Meet25 with a select group of business leaders involved in Vision 2030 to
Excellent! Must watch!!! youtu.be/5QYPW3edX28?si…
youtube.com
YouTube
Anktiva | Cancer Immune Stimulation Isn't Enough Without This?
Imagine the MOST MODERNIZED BIOLOGICALLY BASED AI DRIVEN BIOTECH INDUSTRY based on the mind map I drew up in that slide as far back as 2016. Each of the key immune elements on that slide have now been tested in multiple QUILT FDA authorized trials, across multiple tumor types,
2026 is a decade since I filed this patent on June 2016. The NANT Cancer Vaccine (The Cancer BioShield Platform) is now in full scale development at @ImmunityBio. Finally, the drive to memory NK and T cells for long-term survival is being proven. This figure is another
Just arrived and being hosted by His Excellency Bandar Alknawy. Such a wonderful moment. Ramadan and the year of the Fire Horse, all aligning in a rare moment together on the 17th. Collaboration and Innovation converging for the good of humanity.
United States Trends
- 1. Supreme Court N/A
- 2. SCOTUS N/A
- 3. Congress N/A
- 4. Tariffs N/A
- 5. Finland N/A
- 6. IEEPA N/A
- 7. Kavanaugh N/A
- 8. Canada N/A
- 9. Alito N/A
- 10. Alito N/A
- 11. MacKinnon N/A
- 12. Gorsuch N/A
- 13. Gorsuch N/A
- 14. Roberts N/A
- 15. McConnell N/A
- 16. Saros N/A
- 17. Section 122 N/A
- 18. Pence N/A
- 19. Marchand N/A
- 20. The Court N/A
You might like
-
ImmunityBio, Inc.
@ImmunityBio -
World Health Network
@TheWHN -
Hector Becerra
@hbecerraLATimes -
Dr. Nika Soon-Shiong
@nikasoonshiong -
NantHealth
@NantHealth -
Steve Clow
@steveclowLA -
Steve Padilla
@StevePadilla2 -
Richard Verrier
@rverrier -
Matt Hamilton
@_hamilton_matt -
Laura J. Nelson
@laura_nelson -
Gerry Smith
@gerryfsmith -
Todd Sullivan
@ToddSullivan -
Paul Sonnier
@Paul_Sonnier -
Meg James
@MegJamesLAT -
Andrew Ewing
@AndrewEwing11
Something went wrong.
Something went wrong.